Back
Palvella Therapeutics, Inc. 10K Form
Sell
15
PVLA
Palvella Therapeutics, Inc.
Last Price:
$100.96
Seasonality Move:
132.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PVLA News And Ratings
See the #1 stock for the next 7 days that we like better than PVLA
PVLA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.49 |
| Price / Book: | 30.95 |
Profitability
| EPS (TTM): | -6.56240 |
|---|---|
| Net Income (TTM): | $-35.8M |
| Gross Margin: | $0 |
| Return on Equity: | -101.06% |
| Return on Assets: | -67.33% |
Palvella Therapeutics, Inc. Earnings Forecast
Key Palvella Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 4 years.
Palvella Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | PVLA |
| Website: | palvellatx.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 6.49 |
| Quick Ratio: | 6.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PVLA Technical Analysis vs Fundamental Analysis
Sell
15
Palvella Therapeutics, Inc. (PVLA)
is a Sell
Is Palvella Therapeutics, Inc. a Buy or a Sell?
-
Palvella Therapeutics, Inc. stock is rated a SellThe current Palvella Therapeutics, Inc. [PVLA] share price is $101.15. The Score for PVLA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.